IKS Health Acquires TruBridge Inc for Up to $565 Million

Mumbai-Based Healthcare Tech Firm IKS Health to Acquire US-Based TruBridge Inc for Up to $565 Million

Mumbai: Inventurus Knowledge Solutions (IKS Health), backed by the Jhunjhunwala family, has announced the acquisition of US-based TruBridge Inc, a Nasdaq-listed provider of healthcare technology solutions for rural and community hospitals. The deal, valued at up to $565 million, marks IKS Health's biggest acquisition to date and allows the company to expand its market presence in the US and diversify its offerings.

The acquisition, facilitated through IKS Health's US subsidiary, will be funded by a loan of up to $670 million secured for a five-year term from Citibank, Deutsche Bank, and JPMorgan Chase. Under the terms of the agreement, TruBridge shareholders will receive $26.25 in cash for each share of common stock. The acquisition has been approved by the boards of IKS Health, IKS, and TruBridge, and is expected to close during the third calendar quarter of 2026.

TruBridge is a healthcare IT and revenue cycle management services provider in the US, serving over 700 rural, community, and critical access hospitals with a turnover of $347 million. The acquisition will enable IKS Health to diversify into the sticky SaaS EHR segment—a cloud-based, subscription-model medical software system. The combined company will offer an integrated suite of electronic medical records and Care enablement platform solutions to existing and new clients.

Read also: Microsoft to Offer Buyout Option to Approximately 7% of US Workforce: Report Suggests

Upon completion of the acquisition, TruBridge will become a wholly owned step-down subsidiary of IKS Health, expanding the company's consolidated asset base, revenue streams, and market presence in the US healthcare sector. The combined organization will bring modern revenue cycle management, predictive analytics, and advanced EHR capabilities to support more than 2,000 healthcare organizations and over 150,000 clinicians with a broad portfolio of AI-driven and human-led solutions designed to improve clinical, operational, and financial excellence.